Pfizer Fails To Delay Chantix Trial Despite New Study
An Alabama federal judge on Tuesday refused to grant Pfizer Inc. a stay in the upcoming trial over allegations that its smoking cessation drug Chantix was linked to depression and suicidal...To view the full article, register now.
Already a subscriber? Click here to view full article